Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) Given Average Recommendation of “Hold” by Brokerages

Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) has been given an average recommendation of “Hold” by the eleven analysts that are currently covering the firm, MarketBeat reports. One analyst has rated the stock with a sell recommendation, six have assigned a hold recommendation and four have given a buy recommendation to the company. The average 12 month target price among analysts that have covered the stock in the last year is $21.30.

A number of equities research analysts have recently commented on SBRA shares. Wall Street Zen lowered shares of Sabra Healthcare REIT from a “hold” rating to a “sell” rating in a research note on Saturday. Raymond James Financial started coverage on shares of Sabra Healthcare REIT in a research note on Wednesday, June 17th. They issued an “underperform” rating on the stock. Cantor Fitzgerald upped their price objective on shares of Sabra Healthcare REIT from $21.00 to $22.00 and gave the company a “neutral” rating in a research note on Monday, May 11th. UBS Group set a $19.00 price objective on shares of Sabra Healthcare REIT in a research note on Thursday, June 18th. Finally, Scotiabank reduced their price objective on shares of Sabra Healthcare REIT from $22.00 to $19.00 and set a “sector perform” rating on the stock in a research note on Thursday, June 18th.

Sabra Healthcare REIT Stock Performance

Sabra Healthcare REIT stock opened at $18.63 on Wednesday. The business has a 50 day moving average of $19.82 and a 200-day moving average of $19.64. Sabra Healthcare REIT has a 1 year low of $17.17 and a 1 year high of $21.28. The company has a debt-to-equity ratio of 0.96, a current ratio of 4.72 and a quick ratio of 4.72. The company has a market capitalization of $4.70 billion, a P/E ratio of 29.57, a P/E/G ratio of 1.36 and a beta of 0.64.

Sabra Healthcare REIT (NASDAQ:SBRA) last announced its earnings results on Wednesday, April 29th. The real estate investment trust reported $0.16 EPS for the quarter, meeting the consensus estimate of $0.16. Sabra Healthcare REIT had a return on equity of 5.60% and a net margin of 19.22%.The business had revenue of $211.74 million for the quarter, compared to analysts’ expectations of $209.20 million. During the same period in the prior year, the business posted $0.37 earnings per share. The firm’s revenue was up 20.9% on a year-over-year basis. Sabra Healthcare REIT has set its FY 2026 guidance at 1.550-1.590 EPS. On average, equities research analysts predict that Sabra Healthcare REIT will post 1.5 earnings per share for the current year.

Sabra Healthcare REIT Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, May 29th. Stockholders of record on Friday, May 15th were paid a $0.30 dividend. This represents a $1.20 dividend on an annualized basis and a dividend yield of 6.4%. The ex-dividend date of this dividend was Friday, May 15th. Sabra Healthcare REIT’s dividend payout ratio is currently 190.48%.

Institutional Investors Weigh In On Sabra Healthcare REIT

A number of institutional investors have recently modified their holdings of SBRA. Rothschild Investment LLC boosted its holdings in shares of Sabra Healthcare REIT by 164.6% during the 4th quarter. Rothschild Investment LLC now owns 1,429 shares of the real estate investment trust’s stock worth $27,000 after buying an additional 889 shares in the last quarter. Smartleaf Asset Management LLC boosted its holdings in shares of Sabra Healthcare REIT by 97.7% during the 4th quarter. Smartleaf Asset Management LLC now owns 1,445 shares of the real estate investment trust’s stock worth $27,000 after buying an additional 714 shares in the last quarter. Founders Capital Management bought a new position in shares of Sabra Healthcare REIT during the 3rd quarter worth approximately $28,000. Strengthening Families & Communities LLC bought a new position in shares of Sabra Healthcare REIT during the 4th quarter worth approximately $29,000. Finally, Danske Bank A S bought a new position in shares of Sabra Healthcare REIT during the 3rd quarter worth approximately $30,000. 99.40% of the stock is owned by institutional investors.

About Sabra Healthcare REIT

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.